Strides Pharma Closes Trading Window for Q1 FY27 Results

Strides Pharma Science Ltd has announced the closure of its trading window for dealing in the company's shares. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be shut from July 1, 2026, and will reopen 48 hours after the declaration of the financial results for the quarter ended June 30, 2026. The specific date for the Board Meeting to approve these results will be communicated later. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.